<DOC>
	<DOCNO>NCT02251613</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety Olopatadine Hydrochloride ( HCl ) ophthalmic solution 0.1 % versus Epinastine HCl ophthalmic solution , 0.05 % population healthy , adult Japanese patient ( 20 year age old ) history allergic conjunctivitis Japanese Cedar Pollen . Patients randomly assign receive Olopatadine HCl ophthalmic solution , 0.1 % one eye Epinastine HCl ophthalmic solution , 0.05 % fellow eye , conjunctival allergy challenge ( CAC ) Japanese cedar pollen perform .</brief_summary>
	<brief_title>Effectiveness Olopatadine HCl Ophthalmic Solution Treatment Allergic Conjunctivitis Japan</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Epinastine</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>Be Japanese live Japan ; History allergic conjunctivitis ; Positive skin test reaction Japanese cedar Visit 1 ; Positive bilateral CAC reaction allergen Visit 1 Visit 2 ; Able willing avoid disallow medication specified period ; Able discontinue wear contact lens specified period ; Sign Informed Consent ; Other protocoldefined inclusion criterion may apply . History hypersensitivity study drug compound ; Any ocular condition , opinion investigator , could affect patient 's safety ; Ocular surgical intervention within 3 month refractive surgery within 6 month prior start study ; Presence active ocular infection ; Use disallow medication specify protocol ; Pregnant , nursing , plan become pregnant study ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>